Stockreport

CervoMed to Deliver Oral Presentation at the 8th International Lewy Body Dementia Conference

CervoMed Inc.  (CRVO) 
PDF Topline data from the RewinD-LB Phase 2b study on track for December 2024 Detailed safety and efficacy data from RewinD-LB Phase 2b study to be featured in an oral pres [Read more]